Posted December 10, 2008

Trimeris to pay out $21M in dividend

Print this story

Trimeris (Nasdaq: TRMS) is going to pay a $1 per share dividend to stockholders of record as of Dec. 19.

The biopharmaceutical firm paid a $33.3 million dividend earlier this year.

Trimeris, which developed and sells the HIV drug Fuzeon along with partner Roche, has been under pressure from investors to return more money to investors. Partly as a result Trimeris curtailed new product development and implemented other cost savings.

Trimeris shares trade up 84 cents at $2.84 Wednesday.

Copyright 2012 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Biotech & Life Science

Biotech & Life Science

The latest biotechnology and life science news. Read more articles…

Featured